Acasti pharma to present at lytham partners investor select conference on january 31

Laval, quÉbec, jan. 24, 2023 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced jan d'alvise, ceo, will present and host one-on-one meetings with investors at the lytham partners investor select conference, taking place virtually on january 31, 2023.
ACST Ratings Summary
ACST Quant Ranking